Over a decade ago, Google released the Content API for Shopping to let merchants manage their Google Merchant Center feed programmatically. Well, the new Merchant API is officially replacing the ...

AbbVie plans to spend $195 million to build a new facility to produce active pharmaceutical ingredients in its hometown of North Chicago, Illinois. Construction will begin in the fall, and the site ...

Google Gemini's one of the most powerful features is Deep Research, but up until now, it has been strictly limited to the Gemini interface. This could change soon. With Deep Research in Gemini, you ...

Want smarter insights in your inbox? Sign up for our weekly newsletters to get only what matters to enterprise AI, data, and security leaders. Subscribe Now Updated Friday August 8, 5:21 pm ET: ...

NPCI has issued additional set of guidelines to be adhered by UPI ecosystem members that includes limiting balance enquiry requests to regulating the use of APIs like Autopay Mandate Execution, and ...

Perplexity AI has become one of the most popular AI platforms in recent times for its source-backed results. The more users are joining this AI platform, the more their curiosity about its different ...

Supported Releases: These releases have been certified by Bloomberg’s Enterprise Products team for use by Bloomberg customers. Experimental Releases: These releases have not yet been certified for use ...

With $27 billion earmarked to expand its U.S. production footprint starting this year, Eli Lilly is busy scouting out potential sites for new drug ingredients plants. Eli Lilly is jockeying for a tax ...

OpenAI said on Monday that it would soon wind down the availability of GPT-4.5, its largest-ever AI model, via its API. GPT-4.5 was released only in late February. Developers will have access to GPT-4 ...

Extended anticoagulant therapy with a reduced-dose of apixaban was noninferior to extended therapy with a full-dose of apixaban in preventing recurrent venous thromboembolism (VTE) in patients with ...